FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA

Document

No Title 0.2 MB
Registration Date 12 Nov 2014
Share

AmBisome®

Medicine Pharmaceuticals Product Number : 0469-3051-30

Anti-fungal

Drug Information

Generic
amphotericin B liposomal
NDC Code
0469-3051-30
Drug Class
Polyene
Therapeutic Class
Antifungal
Dosage form
Powder
Route of Administration
Intravenous Injection
Therapeutic Area
1.Fungal infections

Indication

1-Empirical therapy 2-Systemic fungal infections: Aspergillus Candida Cryptococcus 3-Cryptococcal meningitis in HIV infected patients (1- Empirical therapy for presumed fungal infection in febrile neutropenic patients 2- Treatment of Cryptococcal Meningitis in HIV-infected patients 3- Treatment of Aspergillus species, Candida species and/or Cryptococcus species infections refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate 4- Treatment of visceral leishmaniasis; in immunocompromised patients with visceral leishmaniasis treated with AmBisome, relapse rates were high following initial clearance of parasites)